-
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives Consensus Rating of "Moderate Buy" from Brokerages
Source: Buzz FX / 18 Mar 2025 01:16:16 America/Chicago
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Iovance Biotherapeutics, Inc.
Read more...